EMERSON ELECTRIC CO (EMR) Fundamental Analysis & Valuation

NYSE:EMR • US2910111044

Current stock price

138.42 USD
-3.05 (-2.16%)
At close:
137.92 USD
-0.5 (-0.36%)
After Hours:

This EMR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

9

1. EMR Profitability Analysis

1.1 Basic Checks

  • In the past year EMR was profitable.
  • EMR had a positive operating cash flow in the past year.
  • EMR had positive earnings in each of the past 5 years.
  • EMR had a positive operating cash flow in each of the past 5 years.
EMR Yearly Net Income VS EBIT VS OCF VS FCFEMR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

1.2 Ratios

  • EMR has a Return On Assets of 5.51%. This is amongst the best in the industry. EMR outperforms 80.43% of its industry peers.
  • EMR's Return On Equity of 11.40% is amongst the best of the industry. EMR outperforms 82.61% of its industry peers.
  • With an excellent Return On Invested Capital value of 9.17%, EMR belongs to the best of the industry, outperforming 86.96% of the companies in the same industry.
  • EMR had an Average Return On Invested Capital over the past 3 years of 6.24%. This is below the industry average of 9.34%.
  • The 3 year average ROIC (6.24%) for EMR is below the current ROIC(9.17%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 5.51%
ROE 11.4%
ROIC 9.17%
ROA(3y)13.61%
ROA(5y)11.84%
ROE(3y)28.1%
ROE(5y)27.75%
ROIC(3y)6.24%
ROIC(5y)7.7%
EMR Yearly ROA, ROE, ROICEMR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

1.3 Margins

  • EMR's Profit Margin of 12.71% is amongst the best of the industry. EMR outperforms 84.78% of its industry peers.
  • In the last couple of years the Profit Margin of EMR has grown nicely.
  • Looking at the Operating Margin, with a value of 20.36%, EMR belongs to the top of the industry, outperforming 95.65% of the companies in the same industry.
  • In the last couple of years the Operating Margin of EMR has grown nicely.
  • EMR has a better Gross Margin (52.75%) than 98.91% of its industry peers.
  • EMR's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 20.36%
PM (TTM) 12.71%
GM 52.75%
OM growth 3Y4.07%
OM growth 5Y3.94%
PM growth 3Y-18.38%
PM growth 5Y1.69%
GM growth 3Y4.97%
GM growth 5Y4.82%
EMR Yearly Profit, Operating, Gross MarginsEMR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

4

2. EMR Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so EMR is still creating some value.
  • EMR has less shares outstanding than it did 1 year ago.
  • EMR has less shares outstanding than it did 5 years ago.
  • The debt/assets ratio for EMR is higher compared to a year ago.
EMR Yearly Shares OutstandingEMR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M
EMR Yearly Total Debt VS Total AssetsEMR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B

2.2 Solvency

  • EMR has an Altman-Z score of 4.24. This indicates that EMR is financially healthy and has little risk of bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 4.24, EMR is in the better half of the industry, outperforming 69.57% of the companies in the same industry.
  • EMR has a debt to FCF ratio of 5.21. This is a neutral value as EMR would need 5.21 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 5.21, EMR is in the better half of the industry, outperforming 75.00% of the companies in the same industry.
  • A Debt/Equity ratio of 0.37 indicates that EMR is not too dependend on debt financing.
  • EMR has a Debt to Equity ratio of 0.37. This is comparable to the rest of the industry: EMR outperforms 55.43% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.37
Debt/FCF 5.21
Altman-Z 4.24
ROIC/WACC1.13
WACC8.12%
EMR Yearly LT Debt VS Equity VS FCFEMR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B

2.3 Liquidity

  • A Current Ratio of 0.84 indicates that EMR may have some problems paying its short term obligations.
  • EMR's Current ratio of 0.84 is on the low side compared to the rest of the industry. EMR is outperformed by 80.43% of its industry peers.
  • A Quick Ratio of 0.62 indicates that EMR may have some problems paying its short term obligations.
  • EMR's Quick ratio of 0.62 is on the low side compared to the rest of the industry. EMR is outperformed by 78.26% of its industry peers.
Industry RankSector Rank
Current Ratio 0.84
Quick Ratio 0.62
EMR Yearly Current Assets VS Current LiabilitesEMR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

4

3. EMR Growth Analysis

3.1 Past

  • The Earnings Per Share has been growing slightly by 7.61% over the past year.
  • The Earnings Per Share has been growing by 11.64% on average over the past years. This is quite good.
  • EMR shows a small growth in Revenue. In the last year, the Revenue has grown by 3.62%.
  • EMR shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.43% yearly.
EPS 1Y (TTM)7.61%
EPS 3Y4.55%
EPS 5Y11.64%
EPS Q2Q%5.8%
Revenue 1Y (TTM)3.62%
Revenue growth 3Y9.28%
Revenue growth 5Y1.43%
Sales Q2Q%4.1%

3.2 Future

  • EMR is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.19% yearly.
  • The Revenue is expected to grow by 5.50% on average over the next years.
EPS Next Y9.47%
EPS Next 2Y9.69%
EPS Next 3Y9.74%
EPS Next 5Y9.19%
Revenue Next Year4.72%
Revenue Next 2Y5.07%
Revenue Next 3Y5.17%
Revenue Next 5Y5.5%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
EMR Yearly Revenue VS EstimatesEMR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 5B 10B 15B 20B 25B
EMR Yearly EPS VS EstimatesEMR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6 8

5

4. EMR Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 22.77, EMR is valued on the expensive side.
  • Based on the Price/Earnings ratio, EMR is valued cheaply inside the industry as 85.87% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Earnings ratio of 26.91, EMR is valued at the same level.
  • With a Price/Forward Earnings ratio of 19.17, EMR is valued on the expensive side.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of EMR indicates a rather cheap valuation: EMR is cheaper than 84.78% of the companies listed in the same industry.
  • EMR's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 21.99.
Industry RankSector Rank
PE 22.77
Fwd PE 19.17
EMR Price Earnings VS Forward Price EarningsEMR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of EMR indicates a rather cheap valuation: EMR is cheaper than 85.87% of the companies listed in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of EMR indicates a rather cheap valuation: EMR is cheaper than 84.78% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 30.21
EV/EBITDA 17.55
EMR Per share dataEMR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20 30

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • The excellent profitability rating of EMR may justify a higher PE ratio.
PEG (NY)2.4
PEG (5Y)1.96
EPS Next 2Y9.69%
EPS Next 3Y9.74%

5

5. EMR Dividend Analysis

5.1 Amount

  • EMR has a Yearly Dividend Yield of 1.56%.
  • EMR's Dividend Yield is rather good when compared to the industry average which is at 0.24. EMR pays more dividend than 96.74% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.82, EMR has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 1.56%

5.2 History

  • The dividend of EMR has a limited annual growth rate of 1.02%.
  • EMR has been paying a dividend for at least 10 years, so it has a reliable track record.
  • EMR has decreased its dividend in the last 3 years.
Dividend Growth(5Y)1.02%
Div Incr Years2
Div Non Decr Years2
EMR Yearly Dividends per shareEMR Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2 2.5

5.3 Sustainability

  • EMR pays out 52.06% of its income as dividend. This is a bit on the high side, but may be sustainable.
  • The dividend of EMR is growing, but earnings are growing more, so the dividend growth is sustainable.
DP52.06%
EPS Next 2Y9.69%
EPS Next 3Y9.74%
EMR Yearly Income VS Free CF VS DividendEMR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B
EMR Dividend Payout.EMR Dividend Payout, showing the Payout Ratio.EMR Dividend Payout.PayoutRetained Earnings

EMR Fundamentals: All Metrics, Ratios and Statistics

EMERSON ELECTRIC CO

NYSE:EMR (4/28/2026, 7:23:46 PM)

After market: 137.92 -0.5 (-0.36%)

138.42

-3.05 (-2.16%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)02-03
Earnings (Next)05-05
Inst Owners84.46%
Inst Owner Change-0.13%
Ins Owners0.24%
Ins Owner Change1.18%
Market Cap77.79B
Revenue(TTM)18.19B
Net Income(TTM)2.31B
Analysts76
Price Target166.62 (20.37%)
Short Float %2.23%
Short Ratio4.2
Dividend
Industry RankSector Rank
Dividend Yield 1.56%
Yearly Dividend2.1
Dividend Growth(5Y)1.02%
DP52.06%
Div Incr Years2
Div Non Decr Years2
Ex-Date02-13
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.82%
Min EPS beat(2)-0.75%
Max EPS beat(2)2.4%
EPS beat(4)2
Avg EPS beat(4)1.24%
Min EPS beat(4)-0.75%
Max EPS beat(4)3.72%
EPS beat(8)4
Avg EPS beat(8)2.36%
EPS beat(12)7
Avg EPS beat(12)4.59%
EPS beat(16)10
Avg EPS beat(16)4.16%
Revenue beat(2)0
Avg Revenue beat(2)-1.52%
Min Revenue beat(2)-2.02%
Max Revenue beat(2)-1.02%
Revenue beat(4)1
Avg Revenue beat(4)-1.22%
Min Revenue beat(4)-2.02%
Max Revenue beat(4)0.09%
Revenue beat(8)3
Avg Revenue beat(8)-1.07%
Revenue beat(12)6
Avg Revenue beat(12)-0.44%
Revenue beat(16)7
Avg Revenue beat(16)-0.67%
PT rev (1m)-2.31%
PT rev (3m)6.34%
EPS NQ rev (1m)-0.05%
EPS NQ rev (3m)-1.35%
EPS NY rev (1m)-0.19%
EPS NY rev (3m)0.26%
Revenue NQ rev (1m)0.02%
Revenue NQ rev (3m)-0.77%
Revenue NY rev (1m)-0.16%
Revenue NY rev (3m)-0.16%
Valuation
Industry RankSector Rank
PE 22.77
Fwd PE 19.17
P/S 4.28
P/FCF 30.21
P/OCF 25.76
P/B 3.84
P/tB N/A
EV/EBITDA 17.55
EPS(TTM)6.08
EY4.39%
EPS(NY)7.22
Fwd EY5.22%
FCF(TTM)4.58
FCFY3.31%
OCF(TTM)5.37
OCFY3.88%
SpS32.36
BVpS36.08
TBVpS-12.65
PEG (NY)2.4
PEG (5Y)1.96
Graham Number70.2549 (-49.25%)
Profitability
Industry RankSector Rank
ROA 5.51%
ROE 11.4%
ROCE 11.78%
ROIC 9.17%
ROICexc 9.72%
ROICexgc 126.21%
OM 20.36%
PM (TTM) 12.71%
GM 52.75%
FCFM 14.16%
ROA(3y)13.61%
ROA(5y)11.84%
ROE(3y)28.1%
ROE(5y)27.75%
ROIC(3y)6.24%
ROIC(5y)7.7%
ROICexc(3y)7.06%
ROICexc(5y)8.66%
ROICexgc(3y)31.49%
ROICexgc(5y)33.53%
ROCE(3y)8.44%
ROCE(5y)10.31%
ROICexgc growth 3Y8.99%
ROICexgc growth 5Y-0.31%
ROICexc growth 3Y5.37%
ROICexc growth 5Y-11.37%
OM growth 3Y4.07%
OM growth 5Y3.94%
PM growth 3Y-18.38%
PM growth 5Y1.69%
GM growth 3Y4.97%
GM growth 5Y4.82%
F-Score6
Asset Turnover0.43
Health
Industry RankSector Rank
Debt/Equity 0.37
Debt/FCF 5.21
Debt/EBITDA 1.46
Cap/Depr 29.79%
Cap/Sales 2.45%
Interest Coverage 250
Cash Conversion 58.12%
Profit Quality 111.42%
Current Ratio 0.84
Quick Ratio 0.62
Altman-Z 4.24
F-Score6
WACC8.12%
ROIC/WACC1.13
Cap/Depr(3y)29.25%
Cap/Depr(5y)39.76%
Cap/Sales(3y)2.39%
Cap/Sales(5y)2.84%
Profit Quality(3y)88.8%
Profit Quality(5y)94.08%
High Growth Momentum
Growth
EPS 1Y (TTM)7.61%
EPS 3Y4.55%
EPS 5Y11.64%
EPS Q2Q%5.8%
EPS Next Y9.47%
EPS Next 2Y9.69%
EPS Next 3Y9.74%
EPS Next 5Y9.19%
Revenue 1Y (TTM)3.62%
Revenue growth 3Y9.28%
Revenue growth 5Y1.43%
Sales Q2Q%4.1%
Revenue Next Year4.72%
Revenue Next 2Y5.07%
Revenue Next 3Y5.17%
Revenue Next 5Y5.5%
EBIT growth 1Y28.36%
EBIT growth 3Y13.73%
EBIT growth 5Y5.42%
EBIT Next Year22.16%
EBIT Next 3Y12.43%
EBIT Next 5Y9.17%
FCF growth 1Y917.79%
FCF growth 3Y3.71%
FCF growth 5Y0.94%
OCF growth 1Y376.34%
OCF growth 3Y1.97%
OCF growth 5Y0.1%

EMERSON ELECTRIC CO / EMR Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for EMERSON ELECTRIC CO?

ChartMill assigns a fundamental rating of 6 / 10 to EMR.


Can you provide the valuation status for EMERSON ELECTRIC CO?

ChartMill assigns a valuation rating of 5 / 10 to EMERSON ELECTRIC CO (EMR). This can be considered as Fairly Valued.


Can you provide the profitability details for EMERSON ELECTRIC CO?

EMERSON ELECTRIC CO (EMR) has a profitability rating of 9 / 10.


How financially healthy is EMERSON ELECTRIC CO?

The financial health rating of EMERSON ELECTRIC CO (EMR) is 4 / 10.


Is the dividend of EMERSON ELECTRIC CO sustainable?

The dividend rating of EMERSON ELECTRIC CO (EMR) is 5 / 10 and the dividend payout ratio is 52.06%.